The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Covering Every FDA Oncology Approval From October 2025 CURE The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions